Cancer chemotherapy and pregnancy (Q34331656)

1 August 2017

title

Cancer chemotherapy and pregnancy (English)

1 reference

1 August 2017

1 reference

Gideon Koren

1 reference

ORCID Public Data File 2021

1 August 2017

Cynthia Maxwell

1 reference

author name string

Nathalie Carey

1 reference

1 August 2017

Robert Gagnon

1 reference

1 August 2017

Irena Nulman

1 reference

1 August 2017

Vyta Senikas

1 reference

1 August 2017

publication date

1 March 2013

1 reference

Journal of Obstetrics and Gynaecology Canada

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

263-278

1 reference

Cancer in pregnancy: gaps, challenges and solutions

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Chemotherapy and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

1 reference

7 January 2021

Fetal risks of maternal pharmacotherapy: identifying signals

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Medications in pregnancy and lactation: part 1. Teratology

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Thalidomide: an old drug with new clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Use of chemotherapy during human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Fetal effects during cyclophosphamide and irradiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Management of breast cancer during pregnancy using a standardized protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Maternal and foetal outcome following Hodgkin's disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Successful treatment of small cell lung cancer during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Aminopterin and methotrexate: folic acid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Adult and two children with fetal methotrexate syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Methotrexate-induced congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Successful pregnancy during chemotherapy for acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Acute leukemia and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Idarubicin administered during pregnancy: its effects on the fetus.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Taxanes for breast cancer during pregnancy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

The effects of imatinib on pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Pregnancy outcomes after maternal exposure to rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

1 reference

7 January 2021

Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

1 reference

7 January 2021

The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

How I treat acute and chronic leukemia in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Drug therapy for breast-feeding women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Cisplatin excretion in human milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Excretion of platinum into breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Cyclophosphamide in human milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Mitoxantrone and etoposide in breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Imatinib in breast milk.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Imatinib use during pregnancy and breast feeding: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Neurodevelopment of children exposed in utero to treatment of maternal malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930999-3

7 January 2021

10.1016/S1701-2163(15)30999-3

Identifiers

DOI

1 reference

1 August 2017

1 reference